Treating COVID-19 using Micro RNA

 Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists. By time, COVID-19 has developed and adap...

Full description

Saved in:
Bibliographic Details
Main Author: Eskandar Kirolos
Format: Article
Language:English
Published: University of Oran 1 2023-06-01
Series:Journal de la Faculté de Médecine d'Oran
Subjects:
Online Access:https://www.Ajol.Info/index.php/jfmo/article/view/250063
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary: Over 7,805,583 people worldwide are susceptible to death because of infection by an encountered microscopic virus known as Coronavirus. Actually, it is a family of infectious viruses that was first discovered for about 50 years by a group of virologists. By time, COVID-19 has developed and adapted to the surrounding spread prohibitions. That resulted in an incredible increase in the rate of death, in particular for old people who are suffering from other diseases and have frailty in their immunity that permit viruses attacks. Various dense research is under working, as a way to uncover a cure or a vaccine on the long term. Hence, this paper focuses the lights on treating COVID-19 using a brand-new method of non-coding RNA (ncRNA).
ISSN:2571-9874
2602-6511